This is a StreetInsider.com Premium Only Page

NeurogesX, Inc. (NGSX) –

Feb 13, 2017 11:20 AM Form SC 13G/A NeurogesX Inc Filed by: Henriques Charles A.

Feb 9, 2017 04:23 PM Form SC 13G/A NeurogesX Inc Filed by: KCG AMERICAS LLC

Feb 17, 2016 03:01 PM Form SC 13G/A NeurogesX Inc Filed by: Henriques Charles A.

Feb 11, 2016 06:10 AM Form SC 13G/A NeurogesX Inc Filed by: KCG AMERICAS LLC

Jan 7, 2016 02:51 PM Form SC 13G NeurogesX Inc Filed by: Henriques Charles A.

Sep 18, 2015 12:11 PM Form SC 13G/A NeurogesX Inc Filed by: Henriques Charles A.

Sep 17, 2015 10:35 AM Form SC 13G NeurogesX Inc Filed by: Henriques Charles A.

Feb 10, 2015 03:16 PM Form SC 13G NeurogesX Inc Filed by: KCG AMERICAS LLC

Apr 17, 2012 07:58 AM NeurogesX (NGSX) Taps Advisor in Evaluating Development Objectives

Apr 11, 2012 09:26 AM UPDATE: Pre-Open Movers 4/11: (TZOO) (MFRM) (AA) Higher; (NOK) (OPNT) (CSC) Lower (more...)

Apr 11, 2012 07:33 AM NeurogesX (NGSX) Gets FDA Acceptance for End-of-Phase 2 Meeting for NGX-1998

Mar 29, 2012 05:00 PM Neurogesx (NGSX) Files 2.97M Common Shelf for Shareholders

Mar 14, 2012 01:50 PM Wedbush Upgrades NeurogesX, Inc. (NGSX) to Outperform; Restructuring Puts NGX-1998 Liquid Formulation On Center Stage

Mar 8, 2012 07:37 AM NeurogesX (NGSX) Tops Q4 EPS by 7c; Announces Restructuring, Cutting 43 Jobs; Received CRL, FDA Seeking Added Data from Qutenza Trials

Mar 7, 2012 12:26 PM NeurogesX (NGSX) Sees Upside Despite Unlikely FDA Approval

Feb 10, 2012 09:31 AM Pre-Open Movers 2/10: (CIE) (ALU) (LNKD) Higher; (AMRS) (GDI) (LF) Lower (more...)

Feb 9, 2012 06:46 PM After-Hours Movers 02/09: (SWIR) (LNKD) (UEPS) Higher; (NGSX) (XIDE) (TRLG) (NUAN) Lower

Feb 9, 2012 06:13 PM Shares of NeurogesX (NGSX) resume trading down 21%

Feb 9, 2012 05:47 PM NeurogesX (NGSX) Confirms FDA Panel Did Not Recommend Approval of Qutenza

Feb 9, 2012 05:46 PM Shares of NeurogesX (NGSX) to resume trading at 5:50pm ET

Feb 9, 2012 02:35 PM FDA Panel Votes 12-0 Against Effectiveness of NeurogesX's (NGSX) Qutenza

Feb 9, 2012 08:26 AM NeurogesX (NGSX) Halted Ahead of FDA Panel Meeting

Feb 7, 2012 08:47 AM FDA Concerned with Effectiveness of NeurogesX's (NGSX) Qutenza Patch

Feb 7, 2012 08:19 AM NeurogesX (NGSX) Falls After FDA Briefing Documents

Jan 3, 2012 10:05 AM NeurogesX, Inc. (NGSX) Names Ronald Martell President and Chief Executive Officer

Dec 15, 2011 02:42 PM NeurogesX (NGSX) Reports FDA Committee will Review sNDA for Qutenza 8% Patch

Nov 14, 2011 04:11 PM FDA Accepts NeurogesX's (NGSX) Qutenza sNDA for Review

Nov 8, 2011 07:28 AM NeurogesX (NGSX) Reports NGX-1998 Phase 2 Met Primary Endpoint

Oct 31, 2011 04:19 PM NeurogesX, Inc. (NGSX) Posts Q3 Loss of 43c/Share

Oct 31, 2011 08:36 AM NeurogesX (NGSX) Appoints Stephen Peroutka as EVP, CMO

Sep 28, 2011 08:19 AM Wedbush Downgrades NeurogesX, Inc. (NGSX) to Neutral; Mgmt Turnover Increases Uncertainty, Qutenza Ramp Remains Slow

Sep 27, 2011 09:04 AM Jazz Pharma (JAZZ) Taps NeurogesX's (NGSX) Tobias as CMO, R&D Head

Sep 27, 2011 08:36 AM NeurogesX (NGSX) CMO Jeff Tobias MD Resigns

Sep 8, 2011 08:57 AM NeurogesX (NGSX) Submits NDA With FDA for Qutenza 8% Patch for HIV-Associated Peripheral Neuropathy

Aug 24, 2011 05:26 PM Neurogesx (NGSX) Files 17.62M Common Shelf for Selling Shareholders

Aug 9, 2011 08:08 AM NeurogesX, Inc. (NGSX) Posts Wider than Expected Q2 Loss

Aug 8, 2011 04:18 PM NeurogesX (NGSX) Secures $20 Million Debt Facility with Hercules Technology Growth Capital (HTGC)

Jul 22, 2011 10:25 AM NeurogesX (NGSX) Enters $20M SPA

Jun 16, 2011 11:16 AM Morning Movers 06/16: (PVSA) (MDMD) (LPH) (NGSX) Higher; (WGO) (FNSR) (YUII) Lower

Apr 29, 2011 07:12 AM NeurogesX, Inc. (NGSX) Reports Q1 EPS Loss of $0.75

Mar 30, 2011 04:08 PM NeurogesX (NGSX) Reports Inline Q4 Loss of 69c

Nov 4, 2010 11:09 AM Lazard Capital Downgrades NeurogesX, Inc. (NGSX) to Hold

Nov 3, 2010 09:06 AM NeurogesX (NGSX) Posts Wider-than-Expected Q3 Loss

Aug 12, 2010 05:36 PM Neurogesx (NGSX) Files $75M Mixed Shelf

May 11, 2010 04:19 PM NeurogesX, Inc. (NGSX) Posts Q1 Loss of $0.52, Wider than Views

Apr 30, 2010 08:22 AM NeurogesX (NGSX) Enters in to $40M Financing Agreement with Cowen Healthcare Royalty Partners

Mar 23, 2010 08:27 AM Ladenburg Thalmann Initiates Coverage on NeurogesX (NGSX) with a Buy

Mar 18, 2010 04:02 PM NeurogesX (NGSX) Reports Q4 Loss of $0.29, Beats by 5c

Nov 17, 2009 08:59 AM NeurogesX (NGSX) Higher On FDA Approval of Qutenza

Nov 6, 2009 07:39 AM NeurogesX (NGSX) Posts Q3 Loss of 38C, Wider than Expected